CAvent-Ventilation During Advanced Cardiopulmonary Resuscitation in Out-of-hospital Cardiac Arrest- a Descriptive Study (CAvent)

December 20, 2023 updated by: Sten Rubertsson, Uppsala University

The aim with this descriptive multicenter study is to examine the quality of the ventilation given by Emergency Medical Service (EMS) personnel during cardiopulmonary resuscitation (CPR).

Primary endpoint is the ventilation quality measured as ventilation frequency, tidal volume and minute ventilation.

This will primarily be studied during CPR with a 30 compression/2 ventilation ratio performed by the EMS personnel where the airway is managed with a supraglottic device but also in CPR with continuous ventilation (8-10 breaths/minute) after the airway management have been replaced with an endotracheal within the emergency room.

The inclusion of patients will be performed at two sites (Uppsala; Sweden and Utrecht; Holland), all out-of-hospital cardia arrest (OHCA) patients will receive care according to current CPR guidelines using mechanical chest compressions.

Study Overview

Detailed Description

The inclusion is estimated to run over a two-year period to reach the goal of at least 200 patients. The study has been preceded by a trial period in an effort to solve any logistic and technical problems.

The study will be a prospective descriptive multicenter study where measurement of ventilation data will be sampled during CPR by EMS treating patients with OHCA. Any results from standard laboratory tests related to ventilation quality will be retracted from the patient medical journal systems. In addition to ventilatory variables measured as endpoints, secondary endpoints will also be outcome measures as any ROSC, survival and neurological outcome (mRS, GOS-E) measured at 30 days and at 6 months.

Study Type

Observational

Enrollment (Estimated)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Utrecht
      • Amersfoort, Utrecht, Netherlands
        • Recruiting
        • Regionale Ambulance Voorziening Utrecht, Netherlands
        • Contact:
      • Uppsala, Sweden, 75185
        • Recruiting
        • Uppsala University Hospital
        • Contact:
        • Contact:
          • Johan Mälberg, B.Sc.
          • Phone Number: +46706917154

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

Study population will be patients who have suffered an OHCA with CPR started by EMS personnel in Uppsala; Sweden and Utrech, Amersfoort; Holland.

Description

Inclusion Criteria:

Out-of-hospital cardiac arrest (OHCA) treated with CPR performed by the EMS personnel

Exclusion Criteria:

  • Patient age < 18 years
  • Known pregnancy
  • Trauma related cardiac arrest (inc. hanging)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ventilation frequency
Time Frame: From start of CPR to end of CPR.
Measured as ventilations per minute.
From start of CPR to end of CPR.
Tidal volume
Time Frame: From start of CPR to end of CPR.
Measured as milliliters per ventilation.
From start of CPR to end of CPR.
Minute Ventilation
Time Frame: From start of CPR to end of CPR.
Measured as litres per minute.
From start of CPR to end of CPR.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Variation of etCO2 in relation to different ratios of compression to ventilations
Time Frame: From start of CPR to end of CPR.
etCO2 measured as kilopascal for each exhalation during CPR with 30 compressions and 2 ventilations and during continous compressions and ventilations.
From start of CPR to end of CPR.
Time of inspiration
Time Frame: From start to end of CPR.
Measured as seconds for each inspiration.
From start to end of CPR.
Fraction of dead space ventilation
Time Frame: From start of CPR to end of CPR..
Dead space measured as milliliters for each ventilation compared to the tidal volume in milliters for that same ventilation.
From start of CPR to end of CPR..
Peak inspiratory pressure during ventilation
Time Frame: From start of CPR to end of CPR.
Measured as cmH20 for each ventilation.
From start of CPR to end of CPR.
Survival rate
Time Frame: 30 days post cardiac arrest
Number of patients that has survived after the cardiac arrest.
30 days post cardiac arrest
Neurological outcome
Time Frame: 30 days post cardiac arrest
Measured with the modified Ranking Scale (mRS).
30 days post cardiac arrest
Neurological outcome
Time Frame: 30 days post cardiac arrest.
Measured with the Glascow Outcome Scale -Extended (GOS-E).
30 days post cardiac arrest.
Survival rate
Time Frame: 6 months post cardiac arrest
Number of patients that has survived after the cardiac arrest..
6 months post cardiac arrest
Neurological outcome
Time Frame: 6 months post cardiac arrest
Measured with the modified Ranking Scale (mRS).
6 months post cardiac arrest
Neurological outcome
Time Frame: 6 months post cardiac arrest.
Measured with the Glascow Outcome Scale -Extended (GOS-E).
6 months post cardiac arrest.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sten Rubertsson, PhD, Uppsala university department of surgical sciences
  • Study Chair: David Smekal, PhD, Uppsala university department of surgical sciences
  • Study Chair: Johan Mällberg, BsSC, Uppsala university department of surgical sciences
  • Study Chair: René Boomars, MSc, Regionale Ambulance Voorziening Utrecht (RAVU)
  • Study Chair: Thijs Verhagen, MD, Regionale Ambulance Voorziening Utrecht (RAVU)

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 29, 2019

Primary Completion (Estimated)

December 25, 2024

Study Completion (Estimated)

December 30, 2024

Study Registration Dates

First Submitted

April 4, 2019

First Submitted That Met QC Criteria

January 17, 2020

First Posted (Actual)

January 23, 2020

Study Record Updates

Last Update Posted (Estimated)

December 21, 2023

Last Update Submitted That Met QC Criteria

December 20, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Out-of-Hospital Cardiac Arrest

Clinical Trials on Fluxmed GrH will be used to measure the ventilation parameters

3
Subscribe